The Authority identified specific concerns. In particular, it was not possible to conclude on the genotoxic potential of ethoprophos and therefore health-based reference values could not be established. Consequently, the consumer and non-dietary risk assessments could not be conducted. Furthermore, a high acute risk to birds and a high risk to soil dwelling non-target arthropods and soil organisms from the use of ethoprophos were identified. In addition, the Authority concluded that several areas of the risk assessment could not be finalised including the consumer assessment with respect to residues in food of plant and animal origin, the assessment of developmental neurotoxicity, the groundwater exposure assessment, the long-term risk to birds, the assessment of secondary poisoning for birds and mammals, the risk to soil organisms from exposure to metabolites of ethoprophos and the risk to earthworms. Finally, the Authority concluded that assessment of the endocrine disrupting potential of ethoprophos could not be concluded.
Recital 9, Regulation (EU) 2019/344
In forcesince 28 Feb 2019cited 1×
Judgment of the General Court (Seventh Chamber) of 9 February 2022. AMVAC Netherlands BV v European Commission.Decision
First, it should be noted that, as is apparent from recital 9 of the contested implementing regulation, EFSA reported that it had not been possible to draw conclusions as to the genotoxic potential of ethoprophos and thus to establish …
9 Feb 2022 · 62019TJ0317